Erschienen in:
01.05.2021 | Review Article
The role of various interleukins in acute myeloid leukemia
verfasst von:
Erin C. Kaser, Lei Zhao, Kyle P. D’mello, Ziwen Zhu, Huaping Xiao, Mark R. Wakefield, Qian Bai, Yujiang Fang
Erschienen in:
Medical Oncology
|
Ausgabe 5/2021
Einloggen, um Zugang zu erhalten
Abstract
Interleukins are signaling molecules involved in the immune system, and they play a variety of roles in different diseases and cancers. Acute myeloid leukemia (AML) is the most common type of leukemia in adults, and survival rate after diagnosis is very low. Investigating the role interleukins play in AML can help understand the progression of the disease. There exists a need for more effective treatment of AML. Interleukins can be used to guide immunotherapy for AML. This review article will examine how specific interleukins play a role in AML disease progression and how they can be utilized as a future treatment option.